Curis
CRIS
#10201
Rank
A$26.27 M
Marketcap
A$2.03
Share price
0.00%
Change (1 day)
-66.81%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of September 2025 : A$41.61 Million

According to Curis's latest financial reports the company's total assets are A$41.61 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$66.34 M-41.51%
2023-12-31A$0.11 B-29.08%
2022-12-31A$0.15 B-28.55%
2021-12-31A$0.22 B-15.77%
2020-12-31A$0.26 B430.03%
2019-12-31A$50.14 M-5.46%
2018-12-31A$53.03 M-43.89%
2017-12-31A$94.52 M17.98%
2016-12-31A$80.11 M-38.54%
2015-12-31A$0.13 B70.39%
2014-12-31A$76.5 M-15.32%
2013-12-31A$90.35 M34.58%
2012-12-31A$67.13 M42.88%
2011-12-31A$46.98 M-5.76%
2010-12-31A$49.86 M24.08%
2009-12-31A$40.18 M-29.09%
2008-12-31A$56.67 M-7.94%
2007-12-31A$61.55 M-7.16%
2006-12-31A$66.3 M-20.35%
2005-12-31A$83.25 M-4.32%
2004-12-31A$87 M16.04%
2003-12-31A$74.98 M-32.34%
2002-12-31A$0.11 B-60.93%
2001-12-31A$0.28 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Exelixis
EXEL
A$4.25 B 10,115.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.19 B 5,185.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$0.16 B 289.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.97 B 2,245.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 755,049.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.86 B 350,426.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$30.61 M-26.43%๐Ÿ‡บ๐Ÿ‡ธ USA